fbpx
+27 (0)12 844 0144 info@vxpharma.com

VX IN THE NEWS

Read all about it and stay up to date with the latest developments in medical research and breakthrough science & technology

PRESS RELEASES

FLAIR PRESS RELEASE – ViiV Healthcare reports positive 48-week results

   

FDA APPROVAL OF ASTHMA INDICATION FOR DUPIXENT® (DUPILUMAB)

AFFILIATES & ALLIANCES